Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 1860
This article has been cited by
1Saliva Liquid Biopsy for Point-of-Care Applications
Katri Aro,Fang Wei,David T. Wong,Michael Tu
Frontiers in Public Health.2017;5()
[DOI]
2Systematic review and meta-analysis of salivary protein concentration in Parkinson's disease
Joseph M. Masters,Jonathan Bestwick,Thomas T. Warner,Gavin Giovannoni,Gordon B. Proctor,Alastair J. Noyce
Movement Disorders.2015;30(14)1971
[DOI]
3Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinsonís Disease
Fen Xie,Xiaoya Gao,Wanlin Yang,Zihan Chang,Xiaohua Yang,Xiaobo Wei,Zifeng Huang,Huifang Xie,Zhenyu Yue,Fengli Zhou,Qing Wang
ACS Chemical Neuroscience.2019;10(2)973
[DOI]
4Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases
Sahdeo Prasad,Amit K Tyagi,Bharat B Aggarwal
Experimental Biology and Medicine.2016;241(8)783
[DOI]
5Salivary alpha-synuclein as a biomarker for Parkinsonís disease: a systematic review
Anastasia Bougea,Christos Koros,Leonidas Stefanis
Journal of Neural Transmission.2019;126(11)1373
[DOI]
6Methods for detecting toxic a-synuclein species as a biomarker for Parkinsonís disease
Darren M. OíHara,Suneil K. Kalia,Lorraine V. Kalia
Critical Reviews in Clinical Laboratory Sciences.2020;126(11)1
[DOI]
7Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy
Giorgio Vivacqua,Antonio Suppa,Romina Mancinelli,Daniele Belvisi,Andrea Fabbrini,Matteo Costanzo,Alessandra Formica,Paolo Onori,Giovanni Fabbrini,Alfredo Berardelli
Parkinsonism & Related Disorders.2019;63(11)143
[DOI]
8Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease
Marisa Cressatti,Lamin Juwara,Julia M. Galindez,Ana M. Velly,Eva S. Nkurunziza,Sara Marier,Olivia Canie,Mervyn Gornistky,Hyman M. Schipper
Movement Disorders.2020;35(3)468
[DOI]
9Recent developments in circulating biomarkers in Parkinsonís disease: the potential use of miRNAs in a clinical setting
Marcia Cristina Teixeira dos Santos,Rosie Bell,Andre Nogueira da Costa
Bioanalysis.2016;8(23)2497
[DOI]
10The Exosomal/Total a-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients
Silvia Cerri,Cristina Ghezzi,Maria Sampieri,Francesca Siani,Micol Avenali,Gianluca Dornini,Roberta Zangaglia,Brigida Minafra,Fabio Blandini
Frontiers in Cellular Neuroscience.2018;12(23)2497
[DOI]
11Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects
Julien Bonnet,Camille Garcia,Thibaut Leger,Marie-Pauline Couquet,Philippe Vignoles,Gedeao Vatunga,Joseph Ndung'u,Clotilde Boudot,Sylvie Bisser,Bertrand Courtioux
Journal of Proteomics.2019;196(23)150
[DOI]
12Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects
Anastasia Bougea
Journal of Proteomics.2020;196(23)150
[DOI]
13Biomarker sources for Parkinson's disease: Time to shed tears?
M. BŲrger,S. Funke,M. Bšhr,F. Grus,P. Lingor
Basal Ganglia.2015;5(2-3)63
[DOI]
14Oligomeric a-synuclein is increased in basal tears of Parkinsonís patients
Sarah F Hamm-Alvarez,Curtis T Okamoto,Srikanth R Janga,Danielle Feigenbaum,Maria C Edman,Daniel Freire,Mihir Shah,Raveena Ghanshani,Wendy J Mack,Mark F Lew
Biomarkers in Medicine.2019;13(11)941
[DOI]
15Laboratory assessments in the course of Parkinsonís disease: a clinicianís perspective
Thomas MŁller,Horst Baas,Jan Kassubek,Peter Riederer,Peter Paul Urban,Christoph Schrader,Heinz Reichmann,Dirk Woitalla,Manfred Gerlach
Journal of Neural Transmission.2016;123(1)65
[DOI]
16Alpha-Synuclein as a Biomarker for Parkinson's Disease
Anzari Atik,Tessandra Stewart,Jing Zhang
Brain Pathology.2016;26(3)410
[DOI]
17Salivary Biomarkers for Alzheimerís Disease and Related Disorders
Nicholas J. Ashton,Mark Ide,Henrik Zetterberg,Kaj Blennow
Neurology and Therapy.2019;8(S2)83
[DOI]
18Salivary Biomarkers for Alzheimerís Disease and Related Disorders
Gabriel D. Dakubo
Neurology and Therapy.2019;8(S2)47
[DOI]
19Skin Fibroblasts as the Object for Clinical Diagnosis of Parkinsonís Disease in Persons of Different Ages
V. A. Zuev,A. S. Dyatlova,N. S. Liníkova,I. M. Kvetnoi,N. N. Belushkina,V. A. Palítsev
Bulletin of Experimental Biology and Medicine.2019;167(1)177
[DOI]
20Skin Fibroblasts as the Object for Clinical Diagnosis of Parkinsonís Disease in Persons of Different Ages
Sharmistha Dey,Nitish Rai,Shashank Shekhar,Amrendra Pratap Singh,Vertica Agnihotri
Bulletin of Experimental Biology and Medicine.2019;167(1)13
[DOI]
21Skin Fibroblasts as the Object for Clinical Diagnosis of Parkinsonís Disease in Persons of Different Ages
Eva Schaeffer,Ronald B. Postuma,Daniela Berg
Bulletin of Experimental Biology and Medicine.2020;167(1)13
[DOI]
22Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson's disease
Wei Song,Vimal Kothari,Ana M. Velly,Marisa Cressatti,Adrienne Liberman,Mervyn Gornitsky,Hyman M. Schipper
Movement Disorders.2018;33(4)583
[DOI]
23The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease
Naomi P Visanji,Brit Mollenhauer,Thomas G Beach,Charles H Adler,Christopher S Coffey,Catherine M Kopil,Kuldip D Dave,Tatiana Foroud,Lana Chahine,Danna Jennings
Biomarkers in Medicine.2017;11(4)359
[DOI]
24Saliva biomarkers in neurological disorders: A ďspitting imageĒ of brain health?
Emma Louise Walton
Biomedical Journal.2018;41(2)59
[DOI]
25Salivary biomarkers for the diagnosis and†monitoring of neurological diseases
Raymond Farah,Hayat Haraty,Ziad Salame,Youssef Fares,David M. Ojcius,Najwane Said Sadier
Biomedical Journal.2018;41(2)63
[DOI]
26Detection of a-Synuclein in Saliva: The Importance of Preanalytical Assessment
Giorgio Vivacqua,Romina Mancinelli,Daniele Belvisi,Antonio Suppa,Alfredo Berardelli
Movement Disorders.2018;33(6)1029
[DOI]
27Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinsonís Disease
Giorgio Vivacqua,Anna Latorre,Antonio Suppa,Michela Nardi,Sara Pietracupa,Romina Mancinelli,Giovanni Fabbrini,Carlo Colosimo,Eugenio Gaudio,Alfredo Berardelli,Philipp J. Kahle
PLOS ONE.2016;11(3)e0151156
[DOI]
28a-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinsonís disease
Zhentang Cao,Yufeng Wu,Genliang Liu,Ying Jiang,Xuemei Wang,Zhan Wang,Tao Feng
Neuroscience Letters.2019;696(3)114
[DOI]
29Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinsonís disease and healthy controls
Sadhana Kumari,Vinay Goyal,S. Senthil Kumaran,S.N. Dwivedi,Achal Srivastava,N.R. Jagannathan
Neurological Sciences.2020;696(3)114
[DOI]
30Peripheral Biomarkers for Early Detection of Alzheimerís and Parkinsonís Diseases
Thein Than Htike,Sachin Mishra,Sundramurthy Kumar,Parasuraman Padmanabhan,BalŠzs GulyŠs
Molecular Neurobiology.2019;56(3)2256
[DOI]
Feedback
Subscribe

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal